250 related articles for article (PubMed ID: 15845534)
1. Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.
Kim KY; Kovács M; Kawamoto S; Sellers JR; Adelstein RS
J Biol Chem; 2005 Jun; 280(24):22769-75. PubMed ID: 15845534
[TBL] [Abstract][Full Text] [Related]
2. The B2 alternatively spliced isoform of nonmuscle myosin II-B lacks actin-activated MgATPase activity and in vitro motility.
Kim KY; Kawamoto S; Bao J; Sellers JR; Adelstein RS
Biochem Biophys Res Commun; 2008 Apr; 369(1):124-34. PubMed ID: 18060863
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family.
Golomb E; Ma X; Jana SS; Preston YA; Kawamoto S; Shoham NG; Goldin E; Conti MA; Sellers JR; Adelstein RS
J Biol Chem; 2004 Jan; 279(4):2800-8. PubMed ID: 14594953
[TBL] [Abstract][Full Text] [Related]
4. A conserved negatively charged amino acid modulates function in human nonmuscle myosin IIA.
Wang F; Harvey EV; Conti MA; Wei D; Sellers JR
Biochemistry; 2000 May; 39(18):5555-60. PubMed ID: 10820029
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced isoform of non-muscle myosin II-C is not regulated by myosin light chain phosphorylation.
Jana SS; Kim KY; Mao J; Kawamoto S; Sellers JR; Adelstein RS
J Biol Chem; 2009 Apr; 284(17):11563-71. PubMed ID: 19240025
[TBL] [Abstract][Full Text] [Related]
6. Comparative kinetic and functional characterization of the motor domains of human nonmuscle myosin-2C isoforms.
Heissler SM; Manstein DJ
J Biol Chem; 2011 Jun; 286(24):21191-202. PubMed ID: 21478157
[TBL] [Abstract][Full Text] [Related]
7. Two functional heads are required for full activation of smooth muscle myosin.
Li XD; Ikebe M
J Biol Chem; 2003 Aug; 278(32):29435-41. PubMed ID: 12759357
[TBL] [Abstract][Full Text] [Related]
8. A point mutation in the SH1 helix alters elasticity and thermal stability of myosin II.
Iwai S; Hanamoto D; Chaen S
J Biol Chem; 2006 Oct; 281(41):30736-44. PubMed ID: 16901894
[TBL] [Abstract][Full Text] [Related]
9. Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.
Bao J; Jana SS; Adelstein RS
J Biol Chem; 2005 May; 280(20):19594-9. PubMed ID: 15774463
[TBL] [Abstract][Full Text] [Related]
10. Trifluoperazine inhibits the MgATPase activity and in vitro motility of conventional and unconventional myosins.
Sellers JR; Wang F; Chantler PD
J Muscle Res Cell Motil; 2003; 24(8):579-85. PubMed ID: 14870973
[TBL] [Abstract][Full Text] [Related]
11. A point mutation in the motor domain of nonmuscle myosin II-B impairs migration of distinct groups of neurons.
Ma X; Kawamoto S; Hara Y; Adelstein RS
Mol Biol Cell; 2004 Jun; 15(6):2568-79. PubMed ID: 15034141
[TBL] [Abstract][Full Text] [Related]
12. Biological, biochemical, and kinetic effects of mutations of the cardiomyopathy loop of Dictyostelium myosin II: importance of ALA400.
Liu X; Shu S; Kovács M; Korn ED
J Biol Chem; 2005 Jul; 280(29):26974-83. PubMed ID: 15897189
[TBL] [Abstract][Full Text] [Related]
13. Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells.
Wei Q; Adelstein RS
Mol Biol Cell; 2000 Oct; 11(10):3617-27. PubMed ID: 11029059
[TBL] [Abstract][Full Text] [Related]
14. Replacement of nonmuscle myosin II-B with II-A rescues brain but not cardiac defects in mice.
Bao J; Ma X; Liu C; Adelstein RS
J Biol Chem; 2007 Jul; 282(30):22102-11. PubMed ID: 17519229
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of vertebrate nonmuscle myosin IIB isoforms using Dictyostelium chimeric myosin II.
Takahashi M; Takahashi K; Hiratsuka Y; Uchida K; Yamagishi A; Uyeda TQ; Yazawa M
J Biol Chem; 2001 Jan; 276(2):1034-40. PubMed ID: 11042201
[TBL] [Abstract][Full Text] [Related]
16. Mammalian nonmuscle myosin II comes in three flavors.
Shutova MS; Svitkina TM
Biochem Biophys Res Commun; 2018 Nov; 506(2):394-402. PubMed ID: 29550471
[TBL] [Abstract][Full Text] [Related]
17. Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function.
Hu A; Wang F; Sellers JR
J Biol Chem; 2002 Nov; 277(48):46512-7. PubMed ID: 12237319
[TBL] [Abstract][Full Text] [Related]
18. Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis.
Takeda K; Kishi H; Ma X; Yu ZX; Adelstein RS
Circ Res; 2003 Aug; 93(4):330-7. PubMed ID: 12893741
[TBL] [Abstract][Full Text] [Related]
19. Characterization of three full-length human nonmuscle myosin II paralogs.
Billington N; Wang A; Mao J; Adelstein RS; Sellers JR
J Biol Chem; 2013 Nov; 288(46):33398-410. PubMed ID: 24072716
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of the sliding movement of actin filaments with the use of a non-motile mutant myosin in in vitro motility assays driven by skeletal muscle heavy meromyosin.
Iwase K; Tanaka M; Hirose K; Uyeda TQP; Honda H
PLoS One; 2017; 12(7):e0181171. PubMed ID: 28742155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
